MKLNF (M1 Kliniken AG) GF Value Rank: 7 (As of Jul. 25, 2026) — 250% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MKLNF M1 Kliniken AG MKLNF
93 GF Score
Price $11.73
GF Value $10.20
! 2 Warning Signs
View Full Analysis

What is M1 Kliniken AG GF Value Rank?

M1 Kliniken AG MKLNF 93 GF Value Rank is 7 as of Jul. 25, 2026, which is 250% above its 10-year median of 2.00. GuruFocus rates MKLNF with a GF Score™ of 93/100 and a GF Value™ of $10.20. The stock has 2 warning signs investors should review.

M1 Kliniken AG has the GF Value Rank of 7.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

M1 Kliniken AG GF Value Rank Related Terms

MKLNF vs MCK, CAH, COR: GF Value Rank Comparison

For the Medical Distribution subindustry, M1 Kliniken AG's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

M1 Kliniken AG GF Value Rank vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's GF Value Rank distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's GF Value Rank falls into.


MKLNF
93GF Score
M1 Kliniken AG MKLNF
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 7 mean?
M1 Kliniken AG (MKLNF) has a GF Value Rank of 7 as of Jul. 25, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on M1 Kliniken AG and its competitors. This is 250% above median its historical median of 2.00. Over the past decade, M1 Kliniken AG's GF Value Rank has ranged from 1.00 to 10.00.
Is M1 Kliniken AG's GF Value Rank too high?
M1 Kliniken AG's current GF Value Rank of 7 is 250% above median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, M1 Kliniken AG has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's GF Value Rank compare to MCK and CAH?
M1 Kliniken AG's GF Value Rank of 7 can be compared against companies in the Medical Distribution industry. Historically, M1 Kliniken AG's own GF Value Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Medical Distribution company?
A good GF Value Rank depends on the Medical Distribution industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on M1 Kliniken AG and its competitors. M1 Kliniken AG's current GF Value Rank is 7, which is 250% above median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current GF Value Rank of 7. The stock's GF Value™ is $10.20, compared to a current price of $11.73 — trading 15% above its estimated fair value. The current GF Value Rank is 7, which is 250% above median its 10-year median of 2.00. M1 Kliniken AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current GF Value Rank is 7 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M1 Kliniken AG (MKLNF) Overvalued in 2026?

Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued. The current stock price of $11.73 is trading 15% above its estimated GF Value™ of $10.20.

Key valuation signals for MKLNF:

  • GF Value Rank: 7 (250% above median its 10-year median of 2.00)
  • GF Value™: $10.20 vs. price of $11.73 (15% above fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M1 Kliniken AG Business Description

Other Exchanges M12:Germany
Address Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
93GF Score

Get the complete analysis for MKLNF

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.73
Price
$10.20
GF Value